Complaint with Jury Demand Donald Flannigan Against Howmedica Osteonics Corp.. Filing Fee Paid $ 405, Receipt Number AOHNDC-13597373.. Filed by Donald Flannigan. (Taubman, Bruce)
This is a products liability action arising from severe and permanent injuries caused by a defective Stryker hip implant system (“Device”) designed, manufactured, marketed, and sold by Defendant Howmedica Osteonics Corp. d/b/a Stryker Orthopaedics. The Device implanted in Plaintiff included, inter alia:
• Stryker insignia 132 degree femoral stem • Stryker Trident II acetabular cup • Stryker MDM metallic acetabular liner • Stryker V40/C-taper adaptive sleeve • Biolox delta ceramic C-taper femoral head • Stryker X3, MDM dual mobility polyethylene head • Stimulan beads with Incorporated gentamicin and vancomycin • KCI Prevena The Device was defectively designed and/or manufactured such that it was prone to failure, corrosion, fretting, loosening, infection, and the need for early revision surgery, and left the shop in that condition.
Case: 1:26-cv-00751 Doc #: 1 Filed: 03/30/26 1 of 6. PageID #: 1 II.
Device for use in total hip arthroplasty. 2. On or about July 21, 2025, Plaintiff underwent total arthroplasty hip replacement
surgery at UH Lake West Medical Center, 36100 Euclid Ave., Willoughby, OH 44094 during which the Device was implanted. 3. Shortly after implantation, Plaintiff began experiencing complications including
persistent pain, decreased mobility, inflammation and infection. 4. On or about August 7, 2025, Plaintiff required emergency revision surgery due to
infection and inflammatory reaction associated with the Device. 5. Upon information and belief, the Device failed due to one or more defects, including
but not limited to:
a. Improper modular junction design leading to micromotion b. Corrosion and fretting at the taper interface c. Material incompatibility and wear debris generation d. Increased risk of infection associated with device components 6. Defendant knew, or should have known, about the Device’s risks through pre-market
testing, adverse event reports, internal data, and post-market surveillance. Case: 1:26-cv-00751 Doc #: 1 Filed: 03/30/26 2 of 6. PageID #: 2
All claims are brought pursuant to the Ohio Products Liability Act (“OPLA”), R.C. 2307.71 et seq., as Ohio law governs these claims under 28 USC 1332.
b. Conduct adequate testing c. Monitor post-market performance d. Warn of known risks
Plaintiff seeks compensation for:
• Past and future medical expenses • Lost wages and diminished earning capacity • Pain and suffering • Emotional distress • Loss of enjoyment of life • Attorney fees • Court costs • Any other relief the Court deems just and proper Case: 1:26-cv-00751 Doc #: 1 Filed: 03/30/26 4 of 6. PageID #: 4 WHEREFORE, Plaintiff Donald Flannigan demands judgment against Defendant for compensatory damages, costs, interest, and all further legal and equitable relief as may be deemed appropriate. Plaintiff also seeks punitive damages as allowed by law.
Respectfully submitted, /s/ Bruce Taubman Bruce Taubman (0001410) Taubman Law 1444 W. 25th Cleveland, OH 44113 Ph: (216) 621-0794 Fax: (216) 810-2123 [email protected] Attorney for Plaintiff JURY DEMAND
Pursuant to Rule 38(b) of the Federal Rules of Civil Procedure, Plaintiff hereby demands trial by jury.
Respectfully submitted, /s/ Bruce Taubman Bruce Taubman (0001410) Taubman Law 1444 W. 25th Cleveland, OH 44113 Ph: (216) 621-0794 Fax: (216) 810-2123 [email protected] Attorney for Plaintiff
Case: 1:26-cv-00751 Doc #: 1 Filed: 03/30/26 5 of 6. PageID #: 5
Read the full filing
You’re reading pages 1–5 of 6. Register free to read the complete 6-page transcript on this page.
Register free to continue reading →
These are public U.S. federal court records, available free from PACER and the court. Registration unlocks our full on-page transcript — a convenience service.
Public U.S. federal court record (district court docket 73110986, document 1). Source via the RECAP Archive (Free Law Project). The same record is available from PACER. Informational only — not legal advice.